No of subjects | 24 | 24 |
Median (IQR) age at first study | 1.58 (1.07–2.75) | 1.58 (1.12–2.77) |
Sex | 12M (50%) | 14M (52%) |
Genotype | | |
Homozygote | 17 (70.8%) | 19 (70.3%) |
Heterozygote | 7 | 8 |
Compound heterozygote (not F508) | 1 | 1 |
No of visits | 27 | 27 |
No of children with repeat visits | 3 | 3 |
Microbiology at time of visit | | |
No pathogen | 12 (48%) | 13 (48%) |
Mixed oral flora | 3 (12%) | 3 (12%) |
A fumigatus | 1 (4%) | 1 (4%) |
S aureus | 3 (12%) | 3 (12%) |
H influenzae | 1 (4%) | 2 (8%) |
P aeruginosa | 4 (16.7%) | 4 (15%) |
Enterobacter sp | 2 (8%) | 2 (8%) |
C albicans | 1 (4%) | 1 (4%) |
Other | 3 (12%) | 3 (12%) |
Treatments at time of BAL | | |
No antibiotics | | 6 (22.2%) |
Amoxycillin/clavulanate | | 18 (66.7%) |
C/T/S | | 3 (11.1%) |